Clinical implications of antibiotic pharmacokinetic principles in the critically ill. - Wikidata - wikimedia - TriplyDB

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

http://www.wikidata.org/entity/Q38138835

about

Right first time!Antibiotic therapy of pneumonia in the obese patient: dosing and delivery The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.Simplified equations using two concentrations to calculate area under the curve for antimicrobials with concentration-dependent pharmacodynamics: daptomycin as a motivating example Pulmonary penetration of piperacillin and tazobactam in critically ill patients.Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram Treatment of bloodstream infections in ICUs A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations.Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?How to treat infections in a surgical intensive care unit Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.Evaluation of a protocol for vancomycin administration in critically patients with and without kidney dysfunction SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?Bloodstream infections in the Intensive Care Unit.Length of Hospital Stay and Bed Occupancy Rates in Former Yugoslav Republics 1989-2015 Low Caspofungin Exposure in Patients in Intensive Care Units.Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics.Sticking to minimum standards: implementing antibiotic stewardship in intensive care.Treatment option for sepsis in children in the era of antibiotic resistance.Shortening the course of antibiotic treatment in the intensive care unit.Pharmacokinetic considerations for drugs administered in the critically ill.Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).Antibiotic prophylaxis in cirrhosis: Good and bad.Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics.The use and risks of antibiotics in critically ill patients.The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art.Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients.My paper 10 years later: infective endocarditis in the intensive care unit.Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.Is there a role for continuous infusion of β-lactam antibiotics in severe sepsis?Evaluation of Intravenous Vancomycin Pharmacokinetic Parameters in Patients With Acute Brain Injury.Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.Understanding antibiotic stewardship for the critically ill.Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.Unbound fraction of ertapenem in intensive care unit patients.

P2860

Q28067972-66BF2C63-B22F-49CE-9319-67FC9DDA3E2C Q29248400-7624F07F-3F22-4100-9965-387C049E468A Q30238578-7D461262-983A-4EF1-824A-8767740872BF Q33798143-32491B60-4950-42BA-8A2A-DF91654ABAD9 Q34216623-869B4284-F1E1-4546-A96C-CF1D140869FF Q34777837-84B6F8C7-F5FD-4F3E-A4E2-D09398571B6A Q34896896-9AD7FB8C-F892-46DE-AD0B-F519EA5A3637 Q35041939-DB3631EB-096A-4722-9142-3D6967337C05 Q35124710-D0EE12F7-C90B-4974-8770-FEC458E45DEA Q35457224-B5EC56D0-8F25-4A65-819A-53375DA305CF Q35580712-E9104E50-1A6D-4DFD-B8D6-AF3D1CCB218E Q35676081-58DD8007-32A8-4061-B3E9-2AC7E8214713 Q35942407-B0C984D2-363B-44B6-BA35-3344D13F4110 Q36158212-1A765AD2-997D-40BA-B13C-A7D6A46DFEA4 Q36913336-F9659112-DDB7-4DCC-82CA-7F486C3E7951 Q37396917-0409E532-4138-467C-AF47-B8A96A277D6F Q37612914-33FA2183-DCD6-49CF-B05C-5A180E058DDF Q38187368-8384D52B-3476-45CD-A433-9A0398B6229F Q38234816-0A979DCF-9B65-4AC2-B123-9AC01E91EEA1 Q38246118-C8181F94-6C1A-4A18-A9D6-FEC6B6BA065A Q38341882-587E2013-95E3-41E9-AF43-F52EB50EA0FB Q38351793-88AA61C3-3EF7-46A5-B5E6-4F8D8514E2AB Q38528292-E2D0C3C1-7ED2-4B0E-90CA-1B8F15000D03 Q38623328-A0989A03-F0B4-4014-A5F5-EA383847B5E6 Q38644824-42D3FD62-8CA2-43F2-AECF-15AE597D11A8 Q38767901-DAE59692-ACFB-4E75-A93D-B2441B5E5619 Q38837353-276D80BB-76B1-4452-A4B8-9FB471CFA73F Q38884589-3832D1F4-ACC9-453D-882E-8D55915C2E1F Q40095692-90AE65D1-D094-4901-8FB9-16BFEC6D1A94 Q40727311-46C575CA-6EB4-4EBC-9922-272D9419D516 Q41732633-B5678633-36D8-487B-A43C-C2DD0C037668 Q42236097-F1166193-0086-4031-80B7-145648D638FC Q42751350-3F261AB1-A969-4DFB-AE95-7FF728E3C288 Q45073782-47DE0850-E8AB-42C2-BB4C-8A8CC3561FDD Q47861094-7FB2978C-24D7-4A3F-9CBF-C830A31F5B89 Q49056677-56C36AAD-3BBA-4B36-BB49-B8DC667DD477 Q49118898-B6BFF780-4A63-4C5C-B29B-818F99E06084 Q50080880-D8EFD9A7-9295-4F7D-B268-04AF6696BA25 Q50977791-C0C60BB0-42FD-4474-80F5-7CE51A6E7A40 Q52875965-3B1A452C-771F-4374-BA0E-FE91CB3B7A4E

P2860

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

http://www.wikidata.org/entity/Q38138835

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

@en

type

label

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

@en

prefLabel

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

@en

P1433

Q38138835-EE2C2107-C918-4840-8412-7D850CB795ED

P1476

Q38138835-F4DFFF02-1497-4683-A8C7-3FC503A9E202

P2860

Q38138835-076A15FE-C293-4958-8803-6A1AD94AE225

Q38138835-095622E3-7EBD-4C4E-8887-C6C310A882B3

Q38138835-09A47FBC-87C1-4190-AC9F-F022BEA4FD91

Q38138835-0AEB9198-666B-4815-A458-36223229E6CC

Q38138835-0E9060BB-F706-4202-B9EC-B2796E4F90E2

Q38138835-1084732F-E770-49A9-9BDF-48B6CED8AFF3

Q38138835-1833140C-7AE4-400E-8630-1BF195963FA0

Q38138835-19E2EBB2-98FE-43F5-A9E8-D43C105F67A6

Q38138835-1AC1DBAE-8115-44BF-BE7B-C5375934ADB8

Q38138835-1ECD805A-E629-43DE-86FB-B652992FBF05

P2888

Q38138835-38BB029F-2CDC-4EB8-BDA1-7B6E76C34132

P304

Q38138835-EE4BBAF1-F397-493F-B842-CFE56C73FF20

P31

Q38138835-82147BD5-4E73-4160-A964-072F6207D49A

P356

Q38138835-82AD5B39-F0CD-496A-AFFF-C3A90B9A2EF7

P433

Q38138835-DAFA5C94-606F-4047-B54E-911535BDA787

P478

Q38138835-162860FF-FB82-45DB-BF34-91A4F133A6AB

P50

Q38138835-3D93ADF1-A8EA-48A4-8286-7817888B72DB

Q38138835-3E15274B-FCCF-4F8C-A9F9-CA4E9F1574ED

Q38138835-D1197441-6405-4A7B-96CA-F5F4E4CB3D30

P577

Q38138835-38E7B60C-8370-43FD-BFCD-FF28D02B86D4

P5875

Q38138835-D5EC9B9C-D5F8-481C-A827-82C437E3D7DD

P698

Q38138835-7C10BF12-641D-4A38-B4E3-43D8F308AEDF

P921

Q38138835-53AEBA67-E87D-44BB-ACCD-8F04BCFB680D

P356

S00134-013-3088-4

P1433

Intensive Care Medicine

P1476

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

@en

P2860

A new equation to estimate glomerular filtration rate

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

Prediction of creatinine clearance from serum creatinine

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients

Therapeutic drug monitoring of amikacin in septic patients.

Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis.

P2888

s00134-013-3088-4

P304

2070-2082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00134-013-3088-4

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Jason A. Roberts

P577

2013-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256705192

http://www.w3.org/2001/XMLSchema#string

P698

24045886

http://www.w3.org/2001/XMLSchema#string

P921